Patent details

EP2993983 Title: TARGETING CORROLES FOR TUMOR TOXICITY AND MRI

Basic Information

Publication number:
EP2993983
PCT Application Number:
US2014037234
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147944102
PCT Publication Number:
WO2014182868
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TARGETING CORROLES FOR TUMOR TOXICITY AND MRI
French Title of Invention:
CIBLAGE DE CORROLES POUR TOXICITÉ TUMORALE ET IRM
German Title of Invention:
ABZIELUNG AUF CORROLE FÜR TUMORTOXIZITÄT UND MRI
SPC Number:

Dates

Filing date:
08/05/2014
Grant date:
25/03/2020
EP Publication Date:
16/03/2016
PCT Publication Date:
13/11/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2020
EP B1 Publication Date:
25/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/05/2020
Expiration date:
08/05/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2020
 
 

Name:
Cedars-Sinai Medical Center
Address:
8700 Beverly Boulevard, Los Angeles, CA 90048, United States (US)

Inventor

Name:
MEDINA-KAUWE, Lali, K.
Address:
United States (US)

Priority

Priority Number:
201361821106 P
Priority Date:
08/05/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/51; A61K 31/555; A61K 49/10; A61K 49/18;

Publication

European Patent Bulletin

Issue number:
202013
Publication date:
25/03/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages